ALVO
Price
$4.69Alerts
Change
-$0.17 (-3.50%)
Updated
Nov 9 closing price
Capitalization
1.73B
One day until earnings call
Intraday BUY SELL Signals
ZYBT
Price
$1.49Alerts
Change
-$0.01 (-0.67%)
Updated
Nov 9 closing price
Capitalization
71.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALVO vs ZYBT

ALVO vs ZYBT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALVO vs. ZYBT commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and ZYBT is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALVO with price predictions
Nov 09, 2026

ALVO in downward trend: 10-day moving average moved below 50-day moving average on October 22, 2026

The 10-day moving average for ALVO crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

ALVO moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for ALVO entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALVO's RSI Oscillator exited the oversold zone, 30 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 64 cases where ALVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ALVO as a result. In 63 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in 199 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-9.057) is normal, around the industry mean (6.379). P/E Ratio (-7.839) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (3.071) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ALVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for ZYBT with price predictions
Nov 09, 2026

ZYBT in upward trend: price rose above 50-day moving average on November 06, 2026

ZYBT moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 11 of 12 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ZYBT as a result. In 29 of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for ZYBT just turned positive on November 06, 2026. Looking at past instances where ZYBT's MACD turned positive, the stock continued to rise in 9 of 13 cases over the following month. The odds of a continued upward trend are 69%.

Following a +9.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZYBT advanced for three days, in 62 of 77 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

ZYBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for ZYBT moved out of overbought territory on October 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 10 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for ZYBT crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZYBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ZYBT entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ZYBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.656) is normal, around the industry mean (6.379). P/E Ratio (0.000) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (3.795) is also within normal values, averaging (183.387).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZYBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
ALVO: Fundamental Ratings
ALVO
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOZYBT
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (ALVO: $4.69 vs. ZYBT: $1.49)
Brand notoriety: ALVO and ZYBT are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 128% vs. ZYBT: 6%
Market capitalization -- ALVO: $1.73B vs. ZYBT: $71.09M
ALVO [@Pharmaceuticals: Generic] is valued at $1.73B. ZYBT’s [@Pharmaceuticals: Generic] market capitalization is $71.09M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green while ZYBT’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • ZYBT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALVO and ZYBT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish while ZYBT’s TA Score has 5 bullish TA indicator(s).

  • ALVO’s TA Score: 4 bullish, 4 bearish.
  • ZYBT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALVO and ZYBT are a good buy in the short-term.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +4.69% price change this week, while ZYBT (@Pharmaceuticals: Generic) price change was +12.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.25%. For the same industry, the average monthly price growth was -8.53%, and the average quarterly price growth was +7.66%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-3.50%
EBS - ALVO
30%
Poorly correlated
+0.66%
CRON - ALVO
24%
Poorly correlated
-1.94%
PAHC - ALVO
22%
Poorly correlated
+5.01%
ACB - ALVO
22%
Poorly correlated
-1.53%
LFCR - ALVO
21%
Poorly correlated
+0.16%
More

ZYBT and

Correlation & Price change

A.I.dvisor tells us that ZYBT and PRGO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYBT and PRGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYBT
1D Price
Change %
ZYBT100%
-0.67%
PRGO - ZYBT
28%
Poorly correlated
+6.94%
AYTU - ZYBT
27%
Poorly correlated
-2.19%
UTHR - ZYBT
23%
Poorly correlated
+3.64%
NBIX - ZYBT
20%
Poorly correlated
+2.57%
ALVO - ZYBT
15%
Poorly correlated
-3.50%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DZZ1.570.10
+6.80%
Deutsche Bank Ag London Gold Double Short Exchange Traded (Nts) (DZZ)
SEPP32.990.50
+1.53%
PGIM S&P 500 Buffer 12 ETF - September (SEPP)
NFLU11.950.18
+1.53%
T-Rex 2X Long NFLX Daily Target ETF (NFLU)
PJAN50.770.67
+1.34%
Innovator U.S. Equity Power Buffer ETF - January (PJAN)
BSMT22.860.02
+0.11%
Invesco BulletShares 2029 Municipal Bond ETF (BSMT)